The fact that LLMab shows the most promise of any molecule known to treat severe-critical covid is a testament to the likelihood the other indications, the obvious ones it was being developed towards, will be successes as well.

This was never supposed to be an ARDS treatment, in the minds of the creators. But it is. The odds of that... Bordering on miraculous.